HIV Coinfection Is Associated with low-fitness rpoB variants in rifampicin-resistant mycobacterium tuberculosis
- Chloé Loiseau,
- Daniela Brites,
- Miriam Reinhard,
- Kathrin Zürcher,
- Sonia Borrell,
- Marie Ballif
- Swiss Tropical and Public Health Institute,
- University of Basel,
- University of Bern,
- University of Cape Town,
- Ifakara Health Institute,
- Imperial College London
Scholary Output:
Contribution to journal
Article
Peer-reviewOpen access
Sustainable Development Goals
- SDG 3 Good Health and Well
Abstract
We analyzed 312 drug-resistant genomes of Mycobacterium tuberculosis isolates collected from HIV-coinfected and HIV-negative TB patients from nine countries with a high tuberculosis burden. We found that rifampicin-resistant M. tuberculosis strains isolated from HIV-coinfected patients carried disproportionally more resistance-conferring mutations in rpoB that are associated with a low fitness in the absence of the drug, suggesting these low-fitness rpoB variants can thrive in the context of reduced host immunity.
Publication Information
Output type
Scholary Output:
Contribution to journal
Article
Peer-reviewOriginal language
English (US)Article number
e00782Journal (Volume, Issue Number)
Antimicrobial agents and chemotherapy (Volume 64, Issue 10)Publication milestones
- Published - 10/2020
Publication status
Published - 10/2020
ISSN
0066-4804Publication IDs
- Scopus: 85091470049
- PubMed: 32718966
Publication metrics
Metrics
Fractional count
1
Fractional count
0.05
Fractional count
20
Fractional count
0.95
Fractional count
1
Fractional count
1
PlumX, opens in new tab
Captures
91
Citation count
11
Funding Details
Asia-Pacific, U01AI069907; CCASAnet, U01AI069923; Central Africa, U01AI096299; East Africa, U01AI069911; NA-ACCORD, U01AI069918; Southern Africa, U01AI069924; and West Africa, U01AI069919. Informatics resources are supported by the Harmonist Project, R24AI124872. This work is solely the responsibility of the authors and does not necessarily represent the official views of any of the institutions mentioned above. R.J.W. is supported by the Francis Crick Institute, which receives funding from Wellcome (FC0010218), CRUK (FC0010218), and UKR1 (FC0010218). He is also supported by Wellcome (104803 and 203135).
This research was supported by the Swiss National Science Foundation (grant numbers 153442, 310030_188888, 174281, and IZRJZ3_164171). The International Epidemiology Databases to Evaluate AIDS (IeDEA) is supported by the U.S. National Institutes of Health’s National Institute of Allergy and Infectious Diseases, the Eunice Kennedy Shriver National Institute of Child Health and Human Development, the National Cancer Institute, the National Institute of Mental Health, the National Institute on Drug Abuse, the National Heart, Lung, and Blood Institute, the National Institute on Alcohol Abuse and Alcoholism, the National Institute of Diabetes and Digestive and Kidney Diseases, the Fogarty International Center, and the National Library of Medicine:
FundersFunding numbers
UKR1
-NICHD
-NIDDK
-NIMH
-FCI
-NIH
-NIAID
-CRUK
-NCI
-NIDA
-FIC
-NHLBI
-NLM
-NIAAA
-SNF
174281, 310030_188888, 164171, 153442, 188888, IZRJZ3_164171
WT
203135, FC0010218, 104803
Harmonist Project
R24AI124872
